Brandon H. Hull Sells 800 Shares of athenahealth, Inc. (ATHN) Stock

athenahealth, Inc. (NASDAQ:ATHN) Director Brandon H. Hull sold 800 shares of the company’s stock in a transaction on Monday, November 20th. The stock was sold at an average price of $130.00, for a total transaction of $104,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Brandon H. Hull also recently made the following trade(s):

  • On Friday, October 20th, Brandon H. Hull sold 800 shares of athenahealth stock. The stock was sold at an average price of $130.00, for a total transaction of $104,000.00.
  • On Friday, September 1st, Brandon H. Hull sold 800 shares of athenahealth stock. The stock was sold at an average price of $140.95, for a total transaction of $112,760.00.

athenahealth, Inc. (NASDAQ:ATHN) traded down $0.33 during midday trading on Thursday, reaching $130.23. 998,200 shares of the company were exchanged, compared to its average volume of 581,297. The company has a market capitalization of $5,224.71, a PE ratio of 110.64, a P/E/G ratio of 5.19 and a beta of 1.57. athenahealth, Inc. has a twelve month low of $90.11 and a twelve month high of $158.66. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.67 and a current ratio of 1.67.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings data on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.06. The firm had revenue of $304.60 million for the quarter, compared to analysts’ expectations of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The company’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.60 earnings per share. equities analysts predict that athenahealth, Inc. will post 1.13 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Brandon H. Hull Sells 800 Shares of athenahealth, Inc. (ATHN) Stock” was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at https://sportsperspectives.com/2017/11/23/brandon-h-hull-sells-800-shares-of-athenahealth-inc-athn-stock.html.

Institutional investors have recently modified their holdings of the business. Turner Investments LLC bought a new stake in shares of athenahealth during the second quarter valued at approximately $105,000. Bessemer Group Inc. grew its stake in shares of athenahealth by 13.7% during the second quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock valued at $132,000 after purchasing an additional 113 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of athenahealth by 7.7% during the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after purchasing an additional 84 shares during the last quarter. Seven Bridges Advisors LLC grew its stake in shares of athenahealth by 5.4% during the second quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock valued at $183,000 after purchasing an additional 67 shares during the last quarter. Finally, BNP Paribas Arbitrage SA grew its stake in shares of athenahealth by 123.8% during the second quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock valued at $189,000 after purchasing an additional 744 shares during the last quarter.

ATHN has been the subject of a number of research analyst reports. SunTrust Banks, Inc. reissued a “buy” rating and set a $170.00 target price (up previously from $150.00) on shares of athenahealth in a research report on Wednesday, August 2nd. Cowen and Company lowered shares of athenahealth from an “outperform” rating to a “market perform” rating and boosted their target price for the stock from $127.00 to $133.00 in a research report on Monday, July 31st. Morgan Stanley reissued an “equal weight” rating and set a $125.00 target price (up previously from $108.00) on shares of athenahealth in a research report on Wednesday, August 2nd. Oppenheimer Holdings, Inc. reissued a “buy” rating and set a $184.00 target price on shares of athenahealth in a research report on Friday, October 20th. Finally, BidaskClub lowered shares of athenahealth from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and eleven have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $143.22.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply